MyFinsight
Home
About
Contact
cbio: the income statement
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30.
Income Overview
Net Income
-$24,607K
Unit: Thousand (K) dollars
Buy me a coffee
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Income Statement
2025-09-30
2025-06-30
Net loss
-24,607
-21,790
Net loss and comprehensive loss
-24,607
-21,790
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Subscribe for Financial Insights
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Download
Download image
Net loss and
comprehensive loss
-$24,607K
Interest income
$1,278K
Net loss
-$24,607K
Total other income
(expense)
$1,278K
Loss from operations
-$25,885K
Total operating
expenses
$25,885K
General and
administrative
$5,538K
Research and development
$20,347K
Buy me a coffee
CRESCENT BIOPHARMA, INC. (CBIO)
CRESCENT BIOPHARMA, INC. (CBIO)